AlphaTON’s Cyncado Therapeutics teams up with Australia’s ADDRI to launch a groundbreaking investigator-initiated mesothelioma trial of TT-4, perfectly complementing ongoing U.S. clinical efforts and accelerating the fight against cancer
Browsing: cancer research
A pioneering China-Australia research team has uncovered a vital cellular weakness that could revolutionize prostate cancer treatment, offering fresh hope for more powerful and effective therapies against this disease, the South China Morning Post reports
Exciting news from Health Canada! They’ve broadened the approval of Jemperli (dostarlimab) in combination with chemotherapy for all adults facing primary advanced or first recurrent endometrial cancer. This groundbreaking treatment is the first in immuno-oncology to show a remarkable overall survival benefit.
The International Atomic Energy Agency (IAEA) has commenced a visit to India aimed at enhancing collaboration in nuclear energy and cancer treatment. This initiative underscores the importance of safe nuclear technology for sustainable development and healthcare advancements.
A recent Lancet report highlights a groundbreaking cancer therapy that has shown promising results, achieving a 73% success rate in clinical trials among Indian patients. This significant finding could revolutionize treatment options in India and beyond.